Shares of Moderna (NASDAQ:MRNA) are up 14% to $68 and change in afternoon trading Friday, extending a remarkable run for the ...
Merck KGaA agreed to buy Bio-Techne Corporation for $11.3 billion to bolster its life-science business, marking the German ...
The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai ...
Bio-Techne Corp, has agreed to an acquisition offer by Germany’s Merck KGaA for about $11.3 billion, the largest M&A deal ...
June 25 (Reuters) - German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne Corp for $11.3 ...
Merck inaugurates its Global Capability Centre in Bengaluru, enhancing digital innovation and collaboration across its global ...
In 1971, the first all-female crew from the Student Conservation Association came to work at Merck Forest & Farmland Center (MFFC) in Rupert, Vermont, planting, clearing, building, and ...
Wondering whether Merck at US$128.66 is still offering fair value, or if the recent run means you are paying too much for the ...
The top S&P 500 healthcare gainers and losers for the last week are as follows: Bio-Techne ( TECH) +22.58% AbbVie ( ABBV) +17.03% Charles River Laboratories International ( CRL) +16.62% Incyte ( INCY) ...
Merck said on Monday its drug met the main goal in a late-stage trial testing it in patients with a type of ...
Merck has unveiled its 17,000-square-metre Global Capability Centre in Bengaluru, consolidating 3,300 professionals to drive innovation and digital transformation globally.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results